The Case for and Against Array BioPharma Inc. (ARRY)

Array BioPharma Inc. (ARRY) is an interesting player in the Healthcare space, with a focus on Biotechnology. The stock has been active on the tape, currently trading at $18.32, up from yesterday’s close by 2.75%. Given the stock’s recent action, it seemed like a good time to take a closer look at the company’s recent data.

Fundamental Analysis

Array BioPharma Inc. (ARRY) currently trades with a market capitalization of $3.81 Billion. That value represents a market adjusting for revenues that have been growing by 99.42 % on a quarterly year/year basis as of the company’s last quarterly report.

You can get a sense of how sustainable that is by a levered free cash flow of -$75.19 Million over the past twelve months. Generally speaking, earnings are expected to grow in coming quarters. Analysts are forecasting earnings of -$0.26 on a per share basis this quarter. Perhaps, that suggests something about why 1.47% of the outstanding share supply is held by institutional investors.



Technical Analysis

Sometimes, we can understand most about a stock by simply looking at how it has been trading. Looking at the stock’s movement on the chart, Array BioPharma Inc. recorded a 52-week high of $18.78. It is now trading 0.46% off that level. The stock is trading $15.30 its 50-day moving average by -3.02%. The stock carved out a 52-week low down at $7.15.

In recent action, Array BioPharma Inc. (ARRY) has made a move of +16.17% over the past month, which has come on weak relative transaction volume. Over the trailing year, the stock is underperforming the S&P 500 by 14.11, and it’s gotten there by action that has been more volatile on a day-to-day basis than most other stocks on the exchange. In terms of the mechanics underlying that movement, traders will want to note that the stock is trading on a float of 7.64% with $207.84 Million sitting short, betting on future declines. That suggests something of the likelihood of a short squeeze in shares of ARRY.

SHARE
Previous articleDrilling Down Into Frontier Communications Corporation (FTR)
Next articleJust the Facts on Concho Resources Inc. (CXO)